iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
Rapid ART
 
 
  Rapid ART is controversial
 
High rates of virologic suppression after rapid same day ART start in safety-net clinic.....https://www.natap.org/2019/CROI/croi_84.htm
 
HIGH RATES OF VIROLOGIC SUPPRESSION AFTER RAPID same day ART START IN A SAFETY-NET CLINIC.....https://www.natap.org/2019/CROI/croi_167.htm
 
High HIV Control Rate With Rapid D/C/F/TAF in Newly Diagnosed......https://www.natap.org/2019/IDWeek/IDWeek_02.htm......They got their first dose of D/C/F/TAF within 24 hours of screening, before results of initial safety and resistance lab results were available......Median time from HIV diagnosis to enrollment stood at 5 days (range 0 to 14), and 31% of participants enrolled within 48 hours of diagnosis. The Rapid ART Program Initiative for HIV Diagnoses (RAPID) in San Francisco.....https://www.natap.org/2018/CROI/croi_51.htm
 
Assessment of Immediate Initiation of Antiretroviral Therapy (ART) in New York City.....https://www.natap.org/2020/CROI/croi_124.htm
 
RAPID START LEADS TO SUSTAINED VIRAL SUPPRESSION IN YOUNG PEOPLE IN THE SOUTH - New Orleans......https://www.natap.org/2020/CROI/croi_125.htm
 
FEASIBILITY, EFFICACY, AND SAFETY OF USING DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) AS A FIRST-LINE REGIMEN IN A TEST-AND-TREAT SETTING FOR NEWLY DIAGNOSED PEOPLE LIVING WITH HIV (PLWH): THE STAT STUDY - (08/25/20)
 
ViiV Healthcare announces data demonstrating the feasibility of Dovato (dolutegravir/lamivudine) as a treatment option for rapid initiation after diagnosis in adults with HIV-1 - PRESS RELEASE - (08/25/20)
 

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org